You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Russia's "2020 Pharma Strategy" Spurs $2.25 Billion Manufacturing Investment Spike, an Industrial Info Market Brief

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 80 Words
Attachment: Russia-Pharma

Industrial Info's Pharmaceutical-Biotech team is reporting an uptick in drug-manufacturing capital investment in Russia. This is a direct result of the Russian government's "Pharma 2020 Strategy."

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $5.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00